Heidelberg Engineering’s Steve Thomson discusses ANTERION with EyeWireTV
Steve Thomson, Heidelberg’s Clinical Director of Anterior Segment, describes what sets ANTERION apart in the cataract and refractive arena.
Read More
News
Read More
Podcast, Part 2: What is Geographic Atrophy? Making the Invisible, Visible
Host Chris Lievens, OD chats with retinal experts, Jessica Haynes, OD and Steven Ferrucci, OD about the importance of high-quality imaging.
Read More
Podcast, Part 1: What is Geographic Atrophy? Making the Invisible, Visible
Host Chris Lievens, OD sits down with retinal experts, Jessica Haynes, OD and Steven Ferrucci, OD to discuss geographic atrophy. They cover its prevalence and development, the role of high-quality imaging (SPECTRALIS, Heidelberg), and the importance of the doctor-patient relationship.
Read More
Recognizing Common OCT Artifacts for Successful Clinical Management of Glaucoma
Dr. Osamah Saeedi explains why clinicians should be well-versed in potential sources of error on OCT scans in order to make the right decisions for glaucoma patient care.
Read More
ASRS Live: Aaron Lee, MD, shares updates on deep learning research
Dr. Aaron Lee discusses his focus on using AI and big data to uncover associations in eye diseases.
Read More
Assessing damage to ganglion cells through progression models, patterns, and section evaluation
Donald C. Hood, PhD discusses three presentations at ARVO 2023 about glaucoma focusing on the evaluation of the thick doughnut-shaped circle of ganglion cells around the fovea
Read More
Essentials for safe and trustworthy AI model design in ophthalmology
Dr. Brian M. Fernandez spoke about the design of AI models for ophthalmology at DOS Digital Day at ASCRS 2023, emphasizing the need for models to be safe, explainable, and interactive.
Read More
Use of OCT in the quantification of fluid in AMD
This article highlights OCT as an aid in identifying and quantifying abnormal retinal fluids, as well as anatomic changes within the retina.
Read More
The Value of Multimodal Imaging in the Diagnosis and Monitoring of AMD and Geographic Atrophy
For the first time, the U.S. Food and Drug Administration (FDA) has approved a drug for the treatment of geographic atrophy (GA), one of the advanced forms of dry age-related macular degeneration (AMD).
Read More
Closer Examination, Additional Testing, and Patience Lead to LHON Diagnosis
This case study of a patient with Leber hereditary optic neuropathy (LHON) showcases the diagnostic value of the SPECTRALIS.
Read More
